Institutional Fund
Nea Management Company, LLC
Timonium, MDCIK 15128485 filings on record
Portfolio Value
$1.76B
Q1 2026
Holdings
26
Reported positions
New Buys
1
Opened this quarter
QoQ Change
-10.3%
from $1.96B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Arcellx Inc19.9%
- Celcuity Inc14.8%
- Spyglass Pharma Inc10.9%
- Trevi Therapeutics Inc9.0%
- Savara Inc7.6%
- Monte Rosa Therapeutics Inc7.2%
- Other30.7%
Portfolio Holdings
26 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Arcellx Inc | 3.05M | $349.66M | 19.9% | 0 | Held |
| 2 | Celcuity Inc | 2.29M | $260.87M | 14.8% | −1.25M | Reduced |
| 3 | Spyglass Pharma Inc | 7.39M | $191.53M | 10.9% | +7.39M | New |
| 4 | Trevi Therapeutics Inc | 13.22M | $157.74M | 9.0% | 0 | Held |
| 5 | Savara Inc | 24.47M | $133.61M | 7.6% | 0 | Held |
| 6 | Monte Rosa Therapeutics Inc | 7.69M | $126.54M | 7.2% | 0 | Held |
| 7 | Mbx Biosciences Inc | 3.61M | $107.89M | 6.1% | 0 | Held |
| 8 | Zenas Biopharma Inc | 4.02M | $78.65M | 4.5% | +500.0K | Added |
| 9 | Coursera Inc | 12.87M | $74.89M | 4.3% | 0 | Held |
| 10 | Aurinia Pharmaceuticals Inc | 3.97M | $58.83M | 3.3% | 0 | Held |
16 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio